ArticleBrain communications2022

Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.

Alexander J Lowe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.